This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.bbc.co.uk/go/rss/int/news/-/news/uk-england-kent-15584902

The article has changed 3 times. There is an RSS feed of changes available.

Version 0 Version 1
Hundreds of jobs to go at Pfizer site in Sandwich Pfizer site in Sandwich set to retain 650 jobs
(about 2 hours later)
Pharmaceuticals giant Pfizer has said it expects to make another 700 people redundant from its plant in Sandwich. About 650 jobs will remain at the Kent research and development facility of the pharmaceutical giant Pfizer - 300 more than previously announced.
A consultation process on the proposals formally closed on Thursday, a spokeswoman said. It has emerged that about 800 staff have already left their posts at the Sandwich Discovery Park, with a further 700 still to go by the end of 2012.
The company said about 650 jobs would remain at the Sandwich Discovery Park, with a further 250 staff moving to other UK sites. The company said a further 250 staff had moved to other UK sites.
A total of about 1,500 staff will have been made redundant and about 900 staff retained at the end of the process. Pfizer announced in February that its operation, which employs 2,400 people, would close.
A total of about 1,500 staff will have been made redundant and about 900 staff retained by the end of the process.
Phased exitPhased exit
The company announced in February that its operation in Sandwich, which employed 2,400 people, would close. A consultation process on the proposals formally ended on Thursday.
Since then about 800 jobs have already gone. Kent County Council said the site offered an opportunity for new pharmaceutical, "cleantech" and hi-tech research and development companies to start up.
Kent County Council said that the site offered an opportunity for new pharmaceutical, "cleantech" and hi-tech research and development companies to start up. In June Pfizer announced it would retain some operations at its research and development facility.
In June Pfizer announced that it would retain some operations at its research and development facility. The company said it would continue its phased exit of the remainder of the site, on Ramsgate Road, by 2012 and it would review the retained operation within a few years as part of its business planning.
The company said that it would continue its phased exit of the remainder of the site, on Ramsgate Road, by 2012 and it would review the retained operation within a few years as part of its business planning.